Literature DB >> 15560053

Adult liver transplantation for metabolic liver disease.

J A Goss1, R Stribling, P Martin.   

Abstract

Liver replacement provides an effective method of replacing a failing liver, and corrects the underlying defect in many metabolic conditions. Results of liver transplantation for metabolic diseases have been encouraging, with the exception of hereditary hemochromatosis, in which infectious and for which cardiac complications appear to increase posttransplant mortality. An improved understanding of the underlying genetic and molecular defect will lead to advances in medical therapy and perhaps will decrease the need for liver replacement. The prospects of gene therapy are being pursued for many metabolic disorders, however until this research leads to direct clinical application, liver transplantation remains the only effective option for many patients with metabolic liver disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 15560053     DOI: 10.1016/s1089-3261(05)70371-8

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  3 in total

Review 1.  Cardiac evaluation of liver transplant candidates.

Authors:  Mercedes Susan Mandell; Joann Lindenfeld; Mei-Yung Tsou; Michael Zimmerman
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

Review 2.  Advances in Alpha-1 Antitrypsin Gene Therapy.

Authors:  Reka Lorincz; David T Curiel
Journal:  Am J Respir Cell Mol Biol       Date:  2020-11       Impact factor: 6.914

3.  Transdifferentiation of human male germline stem cells to hepatocytes in vivo via the transplantation under renal capsules.

Authors:  Zheng Chen; Minghui Niu; Min Sun; Qingqing Yuan; Chencheng Yao; Jingmei Hou; Hong Wang; Liping Wen; Hongyong Fu; Fan Zhou; Zheng Li; Zuping He
Journal:  Oncotarget       Date:  2017-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.